Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes.

PURPOSE: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes.

PATIENTS AND

METHODS

A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center.

RESULTS

This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease.

CONCLUSIONS

This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.